drugset / Trial / NCT04442919

Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris

NCT04442919

Phase 4 Completed 72 enrolled Collegium Medicum w Bydgoszczy
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate differences in the pharmacokinetics and pharmacodynamics of ticagrelor and its active metabolite in patients who received ticagrelor followed with methoxyflurane versus ticagrelor followed with morphine or ticagrelor alone due to unstable angina pectoris

Timeline

Start
2020-06-01
Primary completion
2024-01-31
Completion
2024-02-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Methoxyflurane Small molecule 3 mg Inhaled
Comparator Morphine Other / unclassified 5 mg Intravenous
Comparator Ticagrelor Small molecule 180 mg